乳腺癌患者癌因性疲乏生物学因素研究进展

摘要/Abstract

摘要：疲乏是乳腺癌患者的常见症状之一，不仅受到心理、社会因素的影响，个体的白细胞介素、肿瘤坏死因子、C反应蛋白水平、神经内分泌功能和儿茶酚O甲基转移酶Val158Met基因多态性等生物学因素对疲乏的发生发展也起着重要的作用。了解乳腺癌患者疲乏的生物学影响因素可为其预防和治疗提供新的视角。

田浪, 曹晓翼, 彭俊平. 乳腺癌患者癌因性疲乏生物学因素研究进展[J]. 国际肿瘤学杂志, 2014, 41(1): 41-44.

Tian Lang, Cao Xiaoyi, Peng Junping. Biological factors related to cancer[J]. Journal of International Oncology, 2014, 41(1): 41-44.

［1］ Newton S, Smith LD. Cancerrelated fatigue: how nurses can help combat this most common symptom［J］. Am J Nurs, 2001, 101 Suppl:S3134. ［2］ Groenvold M, Petersen MA, Idler E, et al. Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients［J］. Breast Cancer Res Treat, 2007, 105(2):209219. ［3］ Orre IJ, Reinertsen KV, Aukrust P, et al. Higher levels of fatigue are associated with higher CRP levels in diseasefree breast cancer survivors［J］. J Psychosom Res, 2011, 71(3):136141. ［4］ ColladoHidalgo A, Bower JE, Ganz PA, et al. Inflammatory biomarkers for persistent fatigue in breast cancer survivors［J］. Clin Cancer Res, 2006, 12(9):27592766. ［5］ Bower JE, Ganz PA, Tao ML, et al. Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer［J］. Clin Cancer Res, 2009, 15(17):55345540. ［6］ Schubert C, Hong S, Natarajan L, et al. The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review ［J］. Brain Behav Immun, 2007, 21(4):413427. ［7］ Bower JE, Ganz PA, Irwin MR, et al. Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? ［J］. J Clin Oncol, 2011, 29(26):35173522. ［8］ Fagundes CP, Glaser R, Alfano CM, et al. Fatigue and herpesvirus latency in women newly diagnosed with breast cancer［J］. Brain Behav Immun, 2012, 26(3):394400. ［9］ FernándezdeLasPeas C, CantareroVillanueva I, FernándezLao C, et al. Influence of catecholomethyltransferase genotype (Val158Met) on endocrine, sympathetic nervous and mucosal immune systems in breast cancer survivors［J］. Breast, 2012, 21(2):199203. ［10］ FernándezdeLasPeas C, FernándezLao C, CantareroVillanueva I, et al. CatecholOmethyltransferase genotype (Val158met) modulates cancerrelated fatigue and pain sensitivity in breast cancer survivors［J］. Breast Cancer Res Treat, 2012,133(2):405412. ［11］ Miaskowski C, Dodd M, Lee K, et al. Preliminary evidence of an association between a functional interleukin6 polymorphism and fatigue and sleep disturbance in oncology patients and their family caregivers［J］. J Pain Symptom Manage, 2010, 40(4):531544. ［12］ ColladoHidalgo A, Bower JE, Ganz PA, et al. Cytokine gene polymorphisms and fatigue in breast cancer survivors: early findings［J］. Brain Behav Immun, 2008, 22(8):11971200. ［13］ Aouizerat BE, Dodd M, Lee K, et al. Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue［J］. Biol Res Nurs, 2009, 11(1):2741. ［14］ Reinertsen KV, Grenaker Alns GI, LandmarkHyvik H, et al. Fatigued breast cancer survivors and gene polymorphisms in the inflammatory pathway［J］. Brain Behav Immun, 2011, 25(7):13761383. ［15］ Bower JE, Ganz PA, Irwin MR, et al. Fatigue and gene expression in human leukocytes: increased NFκB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue［J］. Brain Behav Immun, 2011, 25(1):147150. ［16］ Bower JE, Ganz PA, Aziz N, et al. Inflammatory responses to psychological stress in fatigued breast cancer survivors: relationship to glucocorticoids［J］. Brain Behav Immun, 2007, 21(3):251258. ［17］ Thornton LM, Andersen BL, Blakely WP. The pain, depression, and fatigue symptom cluster in advanced breast cancer: covariation with the hypothalamicpituitaryadrenal axis and the sympathetic nervous system［J］. Health Psychol, 2010, 29(3):333337. ［18］ Fagundes CP, Murray DM, Hwang BS, et al. Sympathetic and parasympathetic activity in cancerrelated fatigue: more evidence for a physiological substrate in cancer survivors［J］. Psychoneuroendocrinology, 2011, 36(8):11371147.

[1]	王盈, 刘楠, 郭兵.抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[2]	萨蔷, 徐航程, 王佳玉.乳腺癌免疫治疗研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 227-234.
[3]	杨智, 陆以乔, 顾花艳, 丁佳玲, 郭贵龙.肿瘤微环境介导乳腺癌靶向治疗耐药的研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 235-238.
[4]	陈波光, 王苏贵, 张永杰.血清胆碱酯酶与炎症标志物在ⅠA~ⅢA期乳腺癌预后中的作用[J]. 国际肿瘤学杂志, 2024, 51(2): 73-82.
[5]	顾花艳, 朱腾, 郭贵龙.乳房微生物群与乳腺癌：现状与未来[J]. 国际肿瘤学杂志, 2024, 51(1): 55-58.
[6]	王景, 许文婷.中性粒细胞与淋巴细胞比值、癌胚抗原联合凝血指标对直径≤1.0 cm的良恶性乳腺结节鉴别诊断价值研究[J]. 国际肿瘤学杂志, 2023, 50(9): 520-526.
[7]	冯诚天, 黄芙蓉, 曹世玉, 王健宇, 南丁阿比雅思, 姜永冬, 朱娟英.HER2阳性乳腺癌患者HER2表达水平与影像学特征的关系[J]. 国际肿瘤学杂志, 2023, 50(9): 527-531.
[8]	冯东旭, 吴炜, 高平发, 王军, 施丽娟, 陈大伟, 李文兵, 张美峰.miR-451通过调控Rho/ROCK1信号通路对乳腺癌细胞糖酵解及凋亡的影响[J]. 国际肿瘤学杂志, 2023, 50(8): 449-456.
[9]	王文德, 曾德.乳腺癌内分泌治疗耐药的机制研究进展[J]. 国际肿瘤学杂志, 2023, 50(6): 352-356.
[10]	李青珊, 谢鑫, 张楠, 刘帅.放疗联合系统治疗在乳腺癌中的应用进展[J]. 国际肿瘤学杂志, 2023, 50(6): 362-367.
[11]	朱军, 黄美金, 李媛, 刘泽刚, 荀欣, 陈宏.HER2低表达乳腺癌的靶向治疗研究进展[J]. 国际肿瘤学杂志, 2023, 50(4): 236-240.
[12]	周婷, 徐少华, 梅林.贝伐珠单抗联合卡培他滨治疗晚期乳腺癌的有效性及安全性[J]. 国际肿瘤学杂志, 2023, 50(3): 144-149.
[13]	黎立喜, 张娣, 罗扬, 马飞.PARP抑制剂在乳腺癌中的临床应用[J]. 国际肿瘤学杂志, 2023, 50(2): 91-96.
[14]	陈群响, 张晓钰, 张妍, 张凯翔, 李捷, 陈曦.伊尼妥单抗联合长春瑞滨治疗HER2阳性转移性乳腺癌1例[J]. 国际肿瘤学杂志, 2023, 50(12): 763-765.
[15]	耿睿, 马俊强, 郭强, 牛钊峰.老年乳腺癌患者的综合治疗方式选择倾向及其影响因素[J]. 国际肿瘤学杂志, 2023, 50(11): 650-654.

乳腺癌患者癌因性疲乏生物学因素研究进展

Biological factors related to cancer

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章15

编辑推荐

Metrics

本文评价